Vaccines in Immunocompromised Patients (2024 AC LIVE)

Only available as part of a package

Learning Objectives:

To understand the importance of - and limitations of - vaccinations in immunocompromised patients. Recognize that differences in vaccine response may be driven by both drug and disease in immunocompromised patients.
To understand recommendations around vaccination, immunosuppressant holding/timing around vaccination, and managing live vaccinations - in an immunocompromised patient population.
To understand the importance of - and challenges so far - to passive immunity strategies like monoclonal antibody pre-exposure prophylaxis.

Manish Jain,MD

Physician, Regional Medical Director and Principal Investigator

Ravenswood Rheumatology and Flourish Research

Keith A. Reich, DO, MACOI, RhMSUS, FACR (he/him/his) (Moderator)

Rheumatologist

University of Chicago Medical Group

I am Dr. Keith A. Reich, DO, MACOI, a rheumatologist at the University of Chicago Medical Group. I have extensive experience in rheumatology care and teaching students, residents, and fellows. My clinical interests include physician-patient communication, inflammatory arthritis and its comorbidities, metabolic bone disease, and musculoskeletal ultrasound.